<?xml version='1.0' encoding='utf-8'?>
<document id="24301608"><sentence text="Amlodipine metabolism in human liver microsomes and roles of CYP3A4/5 in the dihydropyridine dehydrogenation."><entity charOffset="0-10" id="DDI-PubMed.24301608.s1.e0" text="Amlodipine" /><entity charOffset="77-92" id="DDI-PubMed.24301608.s1.e1" text="dihydropyridine" /><pair ddi="false" e1="DDI-PubMed.24301608.s1.e0" e2="DDI-PubMed.24301608.s1.e0" /><pair ddi="false" e1="DDI-PubMed.24301608.s1.e0" e2="DDI-PubMed.24301608.s1.e1" /></sentence><sentence text="Amlodipine is a commonly prescribed calcium channel blocker for the treatment of hypertension and ischemic heart disease"><entity charOffset="0-10" id="DDI-PubMed.24301608.s2.e0" text="Amlodipine" /><entity charOffset="36-43" id="DDI-PubMed.24301608.s2.e1" text="calcium" /><pair ddi="false" e1="DDI-PubMed.24301608.s2.e0" e2="DDI-PubMed.24301608.s2.e0" /><pair ddi="false" e1="DDI-PubMed.24301608.s2.e0" e2="DDI-PubMed.24301608.s2.e1" /></sentence><sentence text=" The drug is slowly cleared in humans primarily via dehydrogenation of its dihydropyridine moiety to a pyridine derivative (M9)"><entity charOffset="75-90" id="DDI-PubMed.24301608.s3.e0" text="dihydropyridine" /><entity charOffset="103-111" id="DDI-PubMed.24301608.s3.e1" text="pyridine" /><pair ddi="false" e1="DDI-PubMed.24301608.s3.e0" e2="DDI-PubMed.24301608.s3.e0" /><pair ddi="false" e1="DDI-PubMed.24301608.s3.e0" e2="DDI-PubMed.24301608.s3.e1" /></sentence><sentence text=" Results from clinical drug-drug interaction studies suggest that CYP3A4/5 mediate metabolism of amlodipine"><entity charOffset="97-107" id="DDI-PubMed.24301608.s4.e0" text="amlodipine" /></sentence><sentence text=" However, attempts to identify a role of CYP3A5 in amlodipine metabolism in humans based on its pharmacokinetic differences between CYP3A5 expressers and nonexpressers failed"><entity charOffset="51-61" id="DDI-PubMed.24301608.s5.e0" text="amlodipine" /></sentence><sentence text=" Objectives of this study were to determine the metabolite profile of amlodipine (a racemic mixture and S-isomer) in human liver microsomes (HLM), and to identify the cytochrome P450 (P450) enzyme(s) involved in the M9 formation"><entity charOffset="70-80" id="DDI-PubMed.24301608.s6.e0" text="amlodipine" /></sentence><sentence text=" Liquid chromatography/mass spectrometry analysis showed that amlodipine was mainly converted to M9 in HLM incubation"><entity charOffset="62-72" id="DDI-PubMed.24301608.s7.e0" text="amlodipine" /></sentence><sentence text=" M9 underwent further O-demethylation, O-dealkylation, and oxidative deamination to various pyridine derivatives"><entity charOffset="92-100" id="DDI-PubMed.24301608.s8.e0" text="pyridine" /></sentence><sentence text=" This observation is consistent with amlodipine metabolism in humans"><entity charOffset="37-47" id="DDI-PubMed.24301608.s9.e0" text="amlodipine" /></sentence><sentence text=" Incubations of amlodipine with HLM in the presence of selective P450 inhibitors showed that both ketoconazole (an inhibitor of CYP3A4/5) and CYP3cide (an inhibitor of CYP3A4) completely blocked the M9 formation, whereas chemical inhibitors of other P450 enzymes had little effect"><entity charOffset="16-26" id="DDI-PubMed.24301608.s10.e0" text="amlodipine" /><entity charOffset="98-110" id="DDI-PubMed.24301608.s10.e1" text="ketoconazole" /><pair ddi="false" e1="DDI-PubMed.24301608.s10.e0" e2="DDI-PubMed.24301608.s10.e0" /><pair ddi="false" e1="DDI-PubMed.24301608.s10.e0" e2="DDI-PubMed.24301608.s10.e1" /></sentence><sentence text=" Furthermore, metabolism of amlodipine in expressed human P450 enzymes showed that only CYP3A4 had significant activity in amlodipine dehydrogenation"><entity charOffset="28-38" id="DDI-PubMed.24301608.s11.e0" text="amlodipine" /><entity charOffset="123-133" id="DDI-PubMed.24301608.s11.e1" text="amlodipine" /><pair ddi="false" e1="DDI-PubMed.24301608.s11.e0" e2="DDI-PubMed.24301608.s11.e0" /><pair ddi="false" e1="DDI-PubMed.24301608.s11.e0" e2="DDI-PubMed.24301608.s11.e1" /></sentence><sentence text=" Metabolite profiles and P450 reaction phenotyping data of a racemic mixture and S-isomer of amlodipine were very similar"><entity charOffset="93-103" id="DDI-PubMed.24301608.s12.e0" text="amlodipine" /></sentence><sentence text=" The results from this study suggest that CYP3A4, rather than CYP3A5, plays a key role in metabolic clearance of amlodipine in humans"><entity charOffset="113-123" id="DDI-PubMed.24301608.s13.e0" text="amlodipine" /></sentence><sentence text=" " /></document>